Interaction of Selected Commercial Antiseptics with Natural Products against Methicillin-Resistant Staphylococcus aureus Strain
Source abstract
Abstract
The carriage of methicillin-resistant S. aureus (MRSA) strains may determine the subsequent occurrence of infection, which mainly affects patients after surgeries. Therefore, its eradication with the use of antibiotics or antiseptics is a crucial method of preventing staphylococcal self-infections. The observed increase in bacterial resistance to known antibacterial substances poses a huge challenge to scientists. The aim of this study was to analyze the interaction of selected commercial antiseptics (Braunol, CITROclorex 2%, Microdacyn 60 Wound Care, Octenisept and Prontoderm Solution) with natural products (carvacrol, β-citronellol, geraniol, eugenol, farnesol, (-)-menthone, eucalyptol, limonene, linalyl acetate and trans-anethole) against the MRSA standard strain. The antistaphylococcal activity of commercial antiseptics in combination with natural products against MRSA was determined using the checkerboard method. The obtained results showed that most combinations decreased the MIC level of the commercial antiseptic and natural compounds. A statistically significant decrease in the MIC value of the antiseptic and natural constituent was observed for the Braunol–β-citronellol combination. Such a significant decrease in the MIC value of the natural compound against the analyzed strain was also detected for the Octenisept–β-citronellol and Prontoderm Solution–β-citronellol combinations. The interaction analysis showed that out of all 20 combinations of individual antiseptics with substances of natural origin, two combinations showed a synergistic effect (Braunol–β-citronellol, Braunol–carvacrol), and three combinations showed an additive effect (Braunol–eugenol, Braunol–geraniol, Prontoderm Solution–β-citronellol). The use of Braunol in combination with β-citronellol or carvacrol may become an alternative method of eradicating MRSA strains. However, further studies are needed to determine the toxicity of the analyzed combinations.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Essential Oils and Antimicrobial Activity · Phenothiazines and Benzothiazines Synthesis and Activities · Antimicrobial agents and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutical Microbiology and Microbiological Diagnostic, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland
Department of Diagnostic Immunology, Pomeranian Medical University in Szczecin, al. Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland
Department of Toxicology, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland
Department of Dietetics and Nutrition Education, Medical University of Lublin, 20-093 Lublin, Poland
References (76)
Show source-provided references
1. Ahmad-Mansour, N., Loubet, P., Pouget, C., Dunyach-Remy, C., Sotto, A., Lavigne, J.-P., and Molle, V. (2021). Staphylococcus aureus toxins: An update on their pathogenic properties and potential treatments. Toxins, 13.10.3390/toxins13100677 ↗
2. Susceptibility of community associated methicillin resistant Staphylococcus aureus isolated from faeces to antiseptics10.3855/jidc.1609 ↗
3. Achraf, A., Fatima Ezzahra, M., Fatima Zahra, M., Abdoullah, B., Nour-Eddine, C., Abdelhakim, E., Eddine Jamal, J., and Mohamed, D. (2023). Antibacterial potent of acetylated and non-acetylated clove bud essential oils and their main compounds. Chem. Biodivers., 20.10.1002/cbdv.202201034 ↗
4. Kwiatkowski, P., Łopusiewicz, Ł., Kostek, M., Drozłowska, E., Pruss, A., Wojciuk, B., Sienkiewicz, M., Zielińska-Bliźiewska, H., and Dołęgowska, B. (2020). The antibacterial activity of lavender essential oil alone and in combination with octenidine dihydrochloride against MRSA strains. Molecules, 25.10.3390/molecules25010095 ↗
5. Frank, D.N., Feazel, L.M., Bessesen, M.T., Prise, C.S., Janoff, E.N., and Pace, N.R. (2010). The human nasal microbiota and Staphylococcus aureus carriage. PLoS ONE, 5.10.1371/journal.pone.0010598 ↗
6. Flouchi, R., Elmniai, A., Hibatallah, A., Fahsi, K., Touzani, I., and Fikri-Benbrahim, K. (2021). The relationship between nasal carriage of Staphylococcus aureus and surgical site infections in a Hospital Center in Morocco. Int. J. Microbiol., 26.10.1155/2021/5585588 ↗
7. Deep sternal wound infections following open heart surgery in Iceland: A population-based study10.1080/14017430801919557 ↗
8. Best products for skin antisepsis10.1016/j.ajic.2019.03.012 ↗
9. Povidone iodine: Properties, mechanisms of action, and role in infection control and Staphylococcus aureus decolonization10.1128/AAC.00682-20 ↗
10. Povidone iodine in wound healing: A review of current concepts and practices10.1016/j.ijsu.2017.06.073 ↗
11. Povidone iodine disinfection associated with hypothyroidism and potentially contributing to prolonged kidney failure
12. Bimetal-organic framework/GOx-based hydrogel dressings with antibacterial and inflammatory modulation for wound healing10.1016/j.actbio.2022.12.049 ↗
13. Chlorhexidine—Pharmaco-biological activity and application
14. Antibiotic resistance as an indicator of bacterial chlorhexidine susceptibility10.1053/jhin.2002.1204 ↗
15. Babalska, Z., Korbecka-Paczkowska, M., and Karpiński, T. (2021). Wound antiseptics and European guidelines for antiseptic application in wound treatment. Pharmaceuticals, 14.10.3390/ph14121253 ↗
16. Efficacy of octenidine against Pseudomonas aeruginosa strains
17. Bock, L.J., Ferguson, P.M., Clarke, M., Pumpitakkul, V., Wand, M.E., Fady, P.-E., Allison, L., Fleck, R.A., Shepherd, M.J., and Mason, A.J. (2021). Pseudomonas aeruginosa adapts to octenidine via a combination of efflux and membrane remodelling. Commun. Biol., 4.10.1038/s42003-021-02566-4 ↗
18. Low-level exposure of MRSA to octenidine dihydrochloride does not select for resistance10.1093/jac/dkm092 ↗
19. Use of 2% 2-phenoxyethanol and 0.1% octenidine as antiseptic in premature newborn infants of 23–26 weeks gestation10.1053/jhin.2002.1249 ↗
20. Antimicrobial preparation Octenisept efficacy study in treatment of inflammatory parodontal diseases
21. Kampf, G. (2018). Antiseptic Stewardship: Biocide Resistance and Clinical Implications, Springer International Publishing.10.1007/978-3-319-98785-9 ↗
22. Cytochrome P450 monooxygenase of Acanthamoeba castellanii participates in resistance to polyhexamethylene biguanide treatment10.1051/parasite/2021074 ↗
23. Polihexanide: A safe and highly effective biocide10.1159/000318237 ↗
24. Hypochlorous acid: A review10.1016/j.joms.2020.06.029 ↗
25. Hypochlorous acid as a potential wound care agent: Part I. Stabilized hypochlorous acid: A component of the inorganic armamentarium of innate immunity
26. Can natural irrigants replace sodium hypochlorite? A systematic review10.1007/s00784-023-04913-7 ↗
27. Phenolic compounds and antimicrobial properties of mint and thyme10.1016/j.hermed.2022.100604 ↗
28. Biological effects of essential oils—A review10.1016/j.fct.2007.09.106 ↗
29. Susceptibility of cariogenic microorganisms to phytoconstituents10.1590/1519-6984.174147 ↗
30. Antibacterial activity of essential oils and their isolated constituents against cariogenic bacteria: A systematic review10.3390/molecules20047329 ↗
31. Composition and functional properties of the essential oil of amazonian basil, Ocimum micranthum Willd., Labiatae in comparison with commercial essential oils10.1021/jf035145e ↗
32. Essential oils: Their antibacterial properties and potential applications in foods—A review10.1016/j.ijfoodmicro.2004.03.022 ↗
33. (2009). Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically, Clinical and Laboratory Standards Institute (CLSI). M07-A9.
34. Basic colorimetric proliferation assays: MTT, WST, and resazurin10.1007/978-1-4939-6960-9_1 ↗
35. Preliminary study on the antibacterial activity of essential oils alone and in combination with gentamicin against extended-spectrum β-lactamase-producing and New Delhi metallo-β-lactamase-1-producing Klebsiella pneumoniae isolates10.1089/mdr.2018.0051 ↗
36. Mogana, R., Adhikari, A., Tzar, M.N., Ramliza, R., and Wiart, C. (2020). Antibacterial activities of the extracts, fractions and isolated compounds from Canarium patentinervium Miq. against bacterial clinical isolates. BMC Complement. Med. Ther., 20.10.1186/s12906-020-2837-5 ↗
37. Combination of essential oils and antibiotics reduce antibiotic resistance in plasmid-conferred multidrug resistant bacteria10.1016/j.phymed.2013.02.013 ↗
38. Cotreatment with aspirin and azole drugs increases sensitivity of Candida albicans in vitro10.2147/IDR.S314538 ↗
39. Chlorhexidine leads to the evolution of antibiotic-resistant Pseudomonas aeruginosa10.1007/s10096-021-04292-5 ↗
40. Kampf, G. (2018). Biocidal agents used for disinfection can enhance antibiotic resistance in Gram-negative species. Antibiotics, 7.10.3390/antibiotics7040110 ↗
41. Mechanism of polyhexamethylene biguanide resistance in Purpureocillium lilacinum strains10.4265/bio.27.117 ↗
42. Dydak, K., Junka, A., Dydak, A., Brożyna, M., Paleczny, J., Fijałkowski, K., Kubielas, G., Aniołek, O., and Bartoszewicz, M. (2021). In vitro efficacy of bacterial cellulose dressings chemisorbed with antiseptics against biofilm formed by pathogens isolated from chronic wounds. Int. J. Mol. Sci., 22.10.3390/ijms22083996 ↗
43. Krasowski, G., Junka, A., Paleczny, J., Czajkowska, J., Makomaska-Szaroszyk, E., Chodaczek, G., Majkowski, M., Migdał, P., Fijałkowski, K., and Kowalska-Krochmal, B. (2021). In-vitro evaluation of polihexanide, octenidine and NaClO/HClO-based antiseptics against biofilm formed by wound pathogens. Membranes, 11.10.3390/membranes11010062 ↗
44. Safety and efficacy profiles of different commercial sodium hypochlorite/hypochlorous acid solutions (NaClO/HClO): Antimicrobial efficacy, cytotoxic impact and physicochemical parameters in vitro10.1093/jac/dky432 ↗
45. Effect of povidone-iodine and propanol-based mecetronium ethyl sulphate on antimicrobial resistance and virulence in Staphylococcus aureus10.1186/s13756-022-01178-9 ↗
46. Standardized comparison of antiseptic efficacy of triclosan, PVP–iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate10.1093/jac/dkq212 ↗
47. Susceptibility of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) to chlorhexidine digluconate, octenidine dihydrochloride, polyhexanide, PVP-iodine and triclosan in comparison to hospital-acquired MRSA (HA-MRSA) and community-acquired MRSA (CA-MRSA): A standardized comparison10.1186/s13756-019-0580-9 ↗
48. Evaluation of toxic side effects of clinically used skin antiseptics in vitro10.1016/j.jss.2009.04.029 ↗
49. Evaluation of a waterless, scrubless chlorhexidine gluconate/ethanol surgical scrub for antimicrobial efficacy10.1067/mic.2001.118842 ↗
50. Resistance and cross-resistance in Staphylococcus spp. strains following prolonged exposure to different antiseptics10.1016/j.jgar.2019.10.021 ↗
51. Chlorhexidine and mupirocin susceptibilities in methicillin-resistant Staphylococcus aureus isolates from bacteraemia and nasal colonisation10.1016/j.jgar.2015.11.005 ↗
52. Phenotypic chlorhexidine and triclosan susceptibility in clinical Staphylococcus aureus isolates in Australia10.1016/j.pathol.2017.05.008 ↗
53. Cieplik, F., Jakubovics, N.S., Buchalla, W., Maisch, T., Hellwig, E., and Al-Ahmad, A. (2019). Resistance toward chlorhexidine in oral bacteria—Is there cause for concern?. Front. Microbiol., 10.10.3389/fmicb.2019.00587 ↗
54. Sauerbrei, A. (2020). Bactericidal and virucidal activity of ethanol and povidone-iodine. Microbiologyopen, 9.10.1002/mbo3.1097 ↗
55. Rozman, U., Duh, D., Cimerman, M., and Turk, S.S. (2022). Hygiene of medical devices and minimum inhibitory concentrations for alcohol-based and QAC disinfectants among isolates from physical therapy departments. Int. J. Environ. Res. Public Health, 19.10.3390/ijerph192214690 ↗
56. Bullous skin lesion reaction as an example of an adverse effect of a preparation containing 0.1% octenidine dihydrochloride and 2% phenoxyethanol (Octenisept®)10.5114/dr.2018.80845 ↗
57. Impact of exposure of methicillin-resistant Staphylococcus aureus to polyhexanide in vitro and in vivo10.1128/AAC.00272-17 ↗
58. Solubilization in vitro of tea tree oil and first results of antifungal effect in onychomycosis
59. Nano-ayurvedic medicine and its potential in cancer treatment10.1016/j.joim.2022.12.001 ↗
60. Selected compounds structurally related to acyclic sesquiterpenoids and their antibacterial and cytotoxic activity10.3390/molecules200611272 ↗
61. Feng, X., Feng, K., Zheng, Q., Tan, W., Zhong, W., Liao, C., Liu, Y., Li, S., and Hu, W. (2022). Preparation and characterization of geraniol nanoemulsions and its antibacterial activity. Front. Microbiol., 13.10.3389/fmicb.2022.1080300 ↗
62. Inhibitory effect of beta-pinene, alpha-pinene and eugenol on the growth of potential infectious endocarditis causing Gram-positive bacteria10.1590/S1516-93322007000100015 ↗
63. Antibacterial effect of combination of cinnamon essential oil and thymol, carvacrol, eugenol, or geraniol10.4103/jrptps.JRPTPS_25_19 ↗
64. Isolation and identification of antibacterial compounds from Thymus kotschyanus aerial parts and Dianthus caryophyllus flower buds10.1016/j.phymed.2008.12.026 ↗
65. Antibacterial activity of essential oils from Eucalyptus and of selected components against multidrug-resistant bacterial pathogens10.3109/13880209.2011.553625 ↗
66. Prevention, removal and inactivation of Escherichia coli and Staphylococcus aureus biofilms using selected monoterpenes of essential oils10.1111/jam.13490 ↗
67. Synergistic antibacterial activity and mechanism of action of nisin/carvacrol combination against Staphylococcus aureus and their application in the infecting pasteurized milk10.1016/j.foodchem.2021.132009 ↗
68. Combined effect of carvacrol, thymol and nisin against Staphylococcus aureus and Salmonella Enteritidis10.1590/0001-3765202120210550 ↗
69. Systematic review and meta-analysis of preoperative antisepsis with combination chlorhexidine and povidone-iodine10.1055/s-0036-1587691 ↗
70. Povidone-iodine irrigation combined with vancomycin powder lowers infection rates in pediatric deformity surgery10.1007/s43390-021-00333-3 ↗
71. Noel, D.J., Keevil, C.W., and Wilks, S.A. (2021). Synergism versus additivity: Defining the interactions between common disinfectants. mBio, 12.10.1128/mBio.02281-21 ↗
72. The influence of the chemical behaviour of iodine on the germicidal action of disinfectant solutions containing iodine10.1016/S0195-6701(85)80040-2 ↗
73. Pharmacological and toxicological properties of eugenol10.4274/tjps.62207 ↗
74. Kim, C.-M., Ko, Y.J., Lee, S.-B., and Jang, S.J. (2022). Adjuvant antimicrobial activity and resensitization efficacy of geraniol in combination with antibiotics on Acinetobacter baumannii clinical isolates. PLoS ONE, 17.10.1371/journal.pone.0271516 ↗
75. Influence of the powder/liquid ratio on the properties of zinc oxide-eugenol-based root canal sealers10.1016/j.dental.2004.02.002 ↗
76. DNA-protective effects of two components of essential plant oils carvacrol and thymol on mammalian cells cultured in vitro